P53
Top View
- P53 Gene Mutations and Abnormal Retinoblastoma Protein in Radiation-Induced Human Sarcomas1
- Involvement of C-Fos in the Promotion of Cancer Stem-Like Cell Properties
- Expression of Androgen Receptor Is Negatively Regulated by P531
- A Global Suppressor Motif for P53 Cancer Mutants
- Transcription Factors WT1 and P53 Combined: a Prognostic Biomarker in Ovarian Cancer
- P53 Overexpression Represses Androgen-Mediated Induction of NKX3.1 in a Prostate Cancer Cell Line
- The Co-Expression of C-Myc and P53 Increases and Reaches a Plateau Early in Oral Oncogenesis
- Mechanisms of Transcriptional Regulation by P53
- TP63 Gene Tumor Protein P63
- Activation of P53 and Destabilization of Androgen Receptor by Combinatorial Inhibition of MDM2 and MDMX in Prostate Cancer Cells
- Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread
- Hyperphosphorylation of Retinoblastoma Protein and P53 by Okadaic Acid, a Tumor Promoter
- Two Sides of the Same Coin: the Roles of KLF6 in Physiology and Pathophysiology
- MYC Oncogene Contributions to Release of Cell Cycle Brakes
- WT1 Induces Expression of Insulin-Like Growth Factor 2 in Wilms' Tumor Cells'
- The WT1 Gene Product Stabilizes P53 and Inhibits P53-Mediated Apoptosis
- Cell Type-Dependent Control of P53 Transcription and Enhancer Activity by P63
- Mutant P53 Partners in Crime